Impact of standard of care medication on valvular oxidative stress in patients with severe mitral regurgitation
Saved in:
| Main Authors: | Raluca Sosdean, Loredana N. Ionica, Alexandru S. Pescariu, Monica Mircea, Adina Ionac, Cristian Mornos, Horea Feier, Constantin T. Luca, Adrian Sturza, Danina M. Muntean |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Journal of Molecular and Cellular Cardiology Plus |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772976124000448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visual grading of valvular regurgitation is inferior to measurement – results from the VIAVA-study (VIsual Assessment of VAlvular Regurgitation)
by: Ozan Demirel, et al.
Published: (2024-11-01) -
Single-cell analysis reveals the loss of FABP4-positive proliferating valvular endothelial cells relates to functional mitral regurgitation
by: Xiaohu Wang, et al.
Published: (2024-12-01) -
Secondary Mitral Regurgitation: Diagnosis and Management
by: Nehal Dhaduk, et al.
Published: (2024-03-01) -
Contemporary Management of Secondary Mitral Regurgitation
by: Kashish Goel, et al.
Published: (2020-05-01) -
Need for expertise in mitral valve regurgitation
by: Elena Galli, et al.
Published: (2019-05-01)